FibroGen, Inc. (KYNB) at a glance
FibroGen, Inc. (KYNB) is a micro-cap Healthcare company. It trades at $6.94, with a P/E of 0.2, a 2199.4% profit margin and revenue growth of 36.5%. It does not pay a dividend. Vestovix scores it 72/100 overall. Its strongest dimension is Value (99/100) and its weakest is Momentum (32/100). Its volatility is roughly in line with the market.
- Price
- $6.94
- Market cap
- $28.9M
- P/E ratio
- 0.2
- Dividend yield
- None
- Beta
- 0.99
- 52-week range
- $4.85 to $12.60
Value
99
Growth
88
Income
40
Safety
70
Momentum
32
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield